Archive for the ‘trial_offer’ tag
Crestor – Arterytour.com site
![]()
Learn about high cholesterol and plaque buildup. Take an interactive artery tour.

Description: This is a very elaborate site on the risks associated with high cholesterol and plaque buildup. It also is a comprehensive sales-pitch for Crestor. Whats new about this Crestor site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.
Click here to visit the site.
To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Internet
Publication: 2009
To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Micardis
My blood pressure went down with Micardis

Telmisartan (INN) is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. It is marketed under the trade names Pritor or Kinzal (Bayer Schering Pharma), Micardis (Boehringer Ingelheim), Telma (Glenmark Pharma), Telday (Torrent Pharmaceuticals) and Teleact D by (Ranbaxy).

Brand name: Micardis
Generic name/category: Telmisartan, Angiotensin II receptor antagonists
Company: Boehringer Ingelheim
Country/Market: USA, North America
Indication(s)/use: High blood pressure, Hypertension
Target: Consumers (DTC)
Medium: Print ad
Size/duration: single-page
Publication/Aired: US News & World Report – September 2009
To see all of this brand’s ads on AdPharm, click here
Crestor – Take action
“Now that I know how plaque can build in my arteries, I'm ready to Take Action.”
Get a Take Action kit to learn about high cholesterol and plaque buildup in arteries -and discover how Crestor can help.
Sig up for a Take Action Kit and get a 30-day free trial offer for Crestor. Go to TakeAction.com today.

Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
In 2008, research emerged that rosuvastatin could reduce the risk of heart attack, stroke, and other vascular complications in patients with elevated C-reactive protein but no other risk factors. This could strongly impact medical practice by placing many patients on statin prophylaxis that otherwise would have been untreated.
The results of the JUPITER trial suggested that rosuvastatin may decrease the relative risk of heart attack and stroke in patients without hyperlipidemia.
The AURORA trial randomized 2776 patients undergoing hemodialysis to receive either rosuvastatin or placebo. The randomized, double-blind study found no difference in the two groups in the primary end point, a combination of cardiovascular mortality, nonfatal myocardial infarction, or nonfatal stroke. The study found no difference in all-cause mortality among this population at a mean follow up of 3.8 years.

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Print ad
Size/duration: single-page plus one-third
Publication: Heart Healthy Living – Fall 2009
To see all Crestor ads, click here
1 views
Sep 07, 2009
Visit AdPharm.net for more pharmaceutical ads
Jeternel beauty clinic – Attractive
Fast wrinkle removal
Jeternel beauty clinic
www.jeternel-lab.ru

Agency: Voskhod, Yekaterinburg, Russia
Creative Director: Andrey Gubaydullin
Art Director: Vladislav Derevynnykh
Copywriter: Evgeny Primachenko
Illustrator and Designer: Dmitry Maslakov
Brand name: Jeternel beauty clinic
Generic name/category: Beauty clinic, aesthetics, dermatology
Country/Market: Russia, Europe
Indication(s)/use: skin_care, wrinkle removal
Target: Consumers (DTC)
Tagline: Fast wrinkle removal
Medium: Print ad
Size/duration: single-page, poster
Publication/Aired: August 2009
Source: Ads of the World
To see all of the ads from this campaign, click here
4 views
Aug 26, 2009
Visit AdPharm.net for more pharmaceutical ads
Jeternel beauty clinic – Beautiful
Fast wrinkle removal
Jeternel beauty clinic
www.jeternel-lab.ru

Agency: Voskhod, Yekaterinburg, Russia
Creative Director: Andrey Gubaydullin
Art Director: Vladislav Derevynnykh
Copywriter: Evgeny Primachenko
Illustrator and Designer: Dmitry Maslakov
Brand name: Jeternel beauty clinic
Generic name/category: Beauty clinic, aesthetics, dermatology
Country/Market: Russia, Europe
Indication(s)/use: skin_care, wrinkle removal
Target: Consumers (DTC)
Tagline: Fast wrinkle removal
Medium: Print ad
Size/duration: single-page, poster
Publication/Aired: August 2009
Source: Ads of the World
To see all of the ads from this campaign, click here
1 views
Aug 26, 2009
Visit AdPharm.net for more pharmaceutical ads




